GF Fund Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.07K Hold
2,737
﹤0.01% 642
2025
Q1
$2.16K Buy
2,737
+346
+14% +$273 ﹤0.01% 646
2024
Q4
$3.95K Buy
+2,391
New +$3.95K ﹤0.01% 618